Investigational Drug Information for Naproxcinod
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Naproxcinod?
Naproxcinod is an investigational drug.
There have been 9 clinical trials for Naproxcinod.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Osteoarthritis, Hypertension, and Osteoarthritis, Knee. The leading clinical trial sponsors are NicOx and [disabled in preview].
Summary for Naproxcinod
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 356 |
| WIPO Patent Applications | 229 |
| Japanese Patent Applications | 70 |
| Clinical Trial Progress | Phase 3 (2007-06-01) |
| Vendors | 27 |
Recent Clinical Trials for Naproxcinod
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male | NicOx | Phase 1 |
| Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide | NicOx | Phase 1 |
| A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function | NicOx | Phase 1 |
Clinical Trial Summary for Naproxcinod
Top disease conditions for Naproxcinod
Top clinical trial sponsors for Naproxcinod
US Patents for Naproxcinod
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
